Free Trial
→ Warning: “DOGE Collapse” imminent (From Altimetry) (Ad) Buy EVTCY Stock  Free EVTCY Stock Alerts

Evotec (EVTCY) Financials

Evotec logo
$4.29 +0.06 (+1.42%)
As of 05/2/2025
Compare
Annual Income Statements for Evotec

Annual Income Statements for Evotec

This table shows Evotec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 54 29 244 -188 -93 -203
Consolidated Net Income / (Loss)		 42 7.67 244 -188 -93 -203
Net Income / (Loss) Continuing Operations		 54 29 244 -188 -93 -203
Total Pre-Tax Income 		75 53 268 -165 -89 -201
Total Operating Income		 -2.10 -25 46 22 -53 -91
Total Gross Profit		 149 154 172 186 194 119
Total Revenue		 501 612 699 804 864 825
Operating Revenue		 501 612 699 804 864 825
Total Cost of Revenue		 352 458 528 618 671 706
Operating Cost of Revenue		 352 458 528 618 671 706
Total Operating Expenses		 151 178 125 164 246 210
Selling, General & Admin Expense		 75 94 119 167 188 195
Research & Development Expense		 66 78 82 82 76 53
Other Operating Expenses / (Income)		 11 6.07 -77 -85 -23 -38
Impairment Charge		 - - 0.77 0.00 5.54 0.00
Total Other Income / (Expense), net		 77 78 222 -187 -37 -110
Interest & Investment Income		 - - 221 -200 -33 -44
Other Income / (Expense), net		 86 88 0.91 13 -3.53 -66
Income Tax Expense		 22 24 24 23 3.67 2.18
Weighted Average Basic Shares Outstanding		 149.73M 153.75M 166.41M 176.67M 177.19M 177.55M
Diluted Earnings per Share		 - - $2.94 ($2.12) ($1.04) ($2.30)
Weighted Average Diluted Shares Outstanding		 149.73M 153.75M 166.41M 176.67M 177.19M 177.55M
Weighted Average Basic & Diluted Shares Outstanding		 149.73M 153.75M 166.41M 176.67M 176.92M 177.30M

Quarterly Income Statements for Evotec

No quarterly income statements for Evotec are available.

Annual Cash Flow Statements for Evotec

This table details how cash moves in and out of Evotec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 187 166 313 -284 375 -135
Net Cash From Operating Activities		 47 175 -27 -161 -29 -27
Net Cash From Continuing Operating Activities		 49 175 -27 -161 -29 -27
Net Income / (Loss) Continuing Operations		 42 7.67 244 -188 -93 -203
Consolidated Net Income / (Loss)		 42 7.67 244 -188 -93 -203
Depreciation Expense		 41 51 80 89 103 105
Non-Cash Adjustments To Reconcile Net Income		 18 89 -354 -198 -40 71
Net Cash From Investing Activities		 -97 -28 -136 -64 286 24
Net Cash From Continuing Investing Activities		 -81 -28 -136 -64 286 24
Purchase of Property, Plant & Equipment		 -36 - -135 -194 -2.96 -15
Sale of Property, Plant & Equipment		 - - 0.00 0.00 0.59 2.07
Sale and/or Maturity of Investments		 - - 31 219 288 37
Net Cash From Financing Activities		 237 18 445 -62 119 -132
Net Cash From Continuing Financing Activities		 237 18 474 -36 119 -132
Repayment of Debt		 -93 -7.96 -18 -36 -125 -133
Issuance of Debt		 328 26 491 0.38 243 0.93
Cash Interest Paid		 - - 6.14 6.13 14 6.13
Cash Interest Received		 - - 1.20 3.24 11 5.85

Quarterly Cash Flow Statements for Evotec

No quarterly cash flow statements for Evotec are available.

Annual Balance Sheets for Evotec

This table presents Evotec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 1,786 2,530 2,415 2,492 1,980
Total Current Assets		 805 1,246 1,149 999 706
Cash & Equivalents		 516 791 444 565 317
Short-Term Investments		 73 180 325 103 94
Accounts Receivable		 97 149 184 109 120
Inventories, net		 17 29 32 34 32
Prepaid Expenses		 37 45 61 57 47
Current Deferred & Refundable Income Taxes		 27 27 58 89 43
Other Current Assets		 - 21 33 28 48
Other Current Nonoperating Assets		 13 0.30 12 14 4.44
Plant, Property, & Equipment, net		 412 548 696 892 853
Plant, Property & Equipment, gross		 412 548 696 892 853
Total Noncurrent Assets		 570 735 427 447 379
Long-Term Investments		 72 319 17 3.40 2.21
Intangible Assets		 120 35 319 322 320
Noncurrent Deferred & Refundable Income Taxes		 74 83 86 120 54
Other Noncurrent Operating Assets		 1.12 6.81 4.05 0.93 3.59
Total Liabilities & Shareholders' Equity		 1,786 2,530 2,415 2,492 1,980
Total Liabilities		 896 954 579 547 498
Total Current Liabilities		 255 367 361 514 357
Accounts Payable		 52 82 104 149 89
Current Deferred & Payable Income Tax Liabilities		 4.11 12 9.61 6.16 8.82
Other Current Liabilities		 175 216 208 183 203
Total Noncurrent Liabilities		 647 603 783 739 637
Noncurrent Deferred & Payable Income Tax Liabilities		 25 20 20 20 15
Other Noncurrent Operating Liabilities		 53 59 238 190 182
Total Equity & Noncontrolling Interests		 885 1,559 1,270 1,239 986
Total Preferred & Common Equity		 885 1,559 1,270 1,239 986
Total Common Equity		 885 1,559 1,270 1,239 986
Common Stock		 1,459 1,819 1,730 1,800 1,690
Retained Earnings		 -529 -245 -420 -527 -696
Accumulated Other Comprehensive Income / (Loss)		 -46 -14 -40 -34 -7.60

Quarterly Balance Sheets for Evotec

No quarterly balance sheets for Evotec are available.

Annual Metrics and Ratios for Evotec

This table displays calculated financial ratios and metrics derived from Evotec's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 22.14% 14.31% 14.93% 7.53% -4.57%
EBITDA Growth		 0.00% -4.88% -3.63% -1.85% -62.47% -209.62%
EBIT Growth		 0.00% -24.44% -25.24% -24.69% -257.42% -178.98%
NOPAT Growth		 0.00% -813.18% 409.02% -63.00% -335.61% -72.52%
Net Income Growth		 0.00% -81.68% 3,080.42% -177.04% 50.60% -118.65%
EPS Growth		 0.00% 0.00% 0.00% -171.98% 50.91% -121.00%
Operating Cash Flow Growth		 0.00% 268.44% -115.43% -498.15% 81.68% -109.17%
Free Cash Flow Firm Growth		 0.00% 0.00% 98.47% -147.06% -713.00% 107.59%
Invested Capital Growth		 0.00% 0.00% 6.88% 5.44% 23.64% -7.45%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 29.77% 25.10% 24.52% 23.16% 22.40% 14.41%
EBITDA Margin		 27.65% 21.53% 18.15% 15.50% 5.41% -6.22%
Operating Margin		 -0.42% -4.07% 6.63% 2.77% -6.08% -10.99%
EBIT Margin		 16.72% 10.34% 6.76% 4.43% -6.49% -18.97%
Profit (Net Income) Margin		 8.36% 1.25% 34.87% -23.38% -10.74% -24.60%
Tax Burden Percent		 55.55% 14.49% 90.94% 114.09% 104.12% 101.08%
Interest Burden Percent		 90.01% 83.66% 566.99% -462.32% 158.97% 128.33%
Effective Tax Rate		 28.83% 45.14% 9.06% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -3.44% 5.14% 1.79% -3.68% -5.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -49.80% -45.05% 39.20% 18.28% 280.65%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 5.18% 14.81% -15.08% -3.72% -12.28%
Return on Equity (ROE)		 0.00% 1.73% 19.96% -13.28% -7.40% -18.25%
Cash Return on Invested Capital (CROIC)		 0.00% -203.44% -1.51% -3.50% -24.82% 1.77%
Operating Return on Assets (OROA)		 0.00% 3.54% 2.19% 1.44% -2.29% -7.00%
Return on Assets (ROA)		 0.00% 0.43% 11.30% -7.60% -3.78% -9.08%
Return on Common Equity (ROCE)		 0.00% 1.73% 19.96% -13.28% -7.40% -18.25%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.87% 15.64% -14.80% -7.49% -20.59%
Net Operating Profit after Tax (NOPAT)		 -1.50 -14 42 16 -37 -63
NOPAT Margin		 -0.30% -2.23% 6.03% 1.94% -4.26% -7.69%
Net Nonoperating Expense Percent (NNEP)		 0.00% 46.36% 50.20% -37.41% -21.96% -286.61%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -6.44%
Cost of Revenue to Revenue		 70.23% 74.90% 75.48% 76.84% 77.60% 85.59%
SG&A Expenses to Revenue		 14.88% 15.41% 17.06% 20.79% 21.71% 23.61%
R&D to Revenue		 13.09% 12.77% 11.68% 10.20% 8.77% 6.38%
Operating Expenses to Revenue		 30.19% 29.17% 17.89% 20.39% 28.48% 25.41%
Earnings before Interest and Taxes (EBIT)		 84 63 47 36 -56 -156
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 139 132 127 125 47 -51
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 1.02 0.30 0.56 0.84 0.37
Price to Tangible Book Value (P/TBV)		 0.00 1.95 0.39 0.75 1.13 0.55
Price to Revenue (P/Rev)		 2.05 1.48 0.68 0.89 1.20 0.45
Price to Earnings (P/E)		 19.16 31.16 1.95 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.22% 3.21% 51.35% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.04 0.00 0.00 0.33 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 1.35 0.00 0.00 0.42 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 6.28 0.00 0.00 7.83 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 13.07 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 4.74 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.66 0.36 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.64 0.34 0.00 0.00 0.00
Financial Leverage		 0.00 -0.10 -0.33 -0.38 -0.20 -0.04
Leverage Ratio		 0.00 2.02 1.77 1.75 1.96 2.01
Compound Leverage Factor		 0.00 1.69 10.01 -8.08 3.11 2.58
Debt to Total Capital		 0.00% 39.72% 26.57% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 1.28% 1.93% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 38.44% 24.64% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 60.28% 73.43% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 4.43 4.44 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 -0.59 -5.72 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 4.28 4.12 0.00 0.00 0.00
Debt to NOPAT		 0.00 -42.71 13.37 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 5.69 -17.21 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 -41.33 12.40 0.00 0.00 0.00
Altman Z-Score		 0.00 1.02 0.92 1.27 1.35 0.32
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 3.16 3.39 3.18 1.94 1.98
Quick Ratio		 0.00 2.75 3.05 2.64 1.51 1.49
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -807 -12 -31 -248 19
Operating Cash Flow to CapEx		 132.32% 0.00% -20.00% -83.02% -1,242.06% -201.29%
Free Cash Flow to Firm to Interest Expense		 0.00 -78.01 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 5.66 16.88 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 1.38 16.88 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.34 0.32 0.33 0.35 0.37
Accounts Receivable Turnover		 0.00 6.34 5.69 4.82 5.91 7.20
Inventory Turnover		 0.00 27.62 23.06 20.22 20.30 21.27
Fixed Asset Turnover		 0.00 1.49 1.46 1.29 1.09 0.95
Accounts Payable Turnover		 0.00 8.82 7.87 6.63 5.31 5.95
Days Sales Outstanding (DSO)		 0.00 57.57 64.18 75.66 61.78 50.72
Days Inventory Outstanding (DIO)		 0.00 13.22 15.83 18.05 17.98 17.16
Days Payable Outstanding (DPO)		 0.00 41.39 46.37 55.02 68.74 61.36
Cash Conversion Cycle (CCC)		 0.00 29.39 33.64 38.69 11.02 6.51
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 793 848 894 1,105 1,023
Invested Capital Turnover		 0.00 1.54 0.85 0.92 0.87 0.78
Increase / (Decrease) in Invested Capital		 0.00 793 55 46 211 -82
Enterprise Value (EV)		 0.00 827 -251 -71 366 -44
Market Capitalization		 1,028 905 475 714 1,038 369
Book Value per Share		 $0.00 $5.76 $9.37 $7.19 $7.00 $5.56
Tangible Book Value per Share		 $0.00 $3.01 $7.41 $5.38 $5.18 $3.76
Total Capital		 0.00 1,468 2,123 1,270 1,239 986
Total Debt		 0.00 583 564 0.00 0.00 0.00
Total Long-Term Debt		 0.00 564 523 0.00 0.00 0.00
Net Debt		 0.00 -78 -726 -786 -672 -413
Capital Expenditures (CapEx)		 36 0.00 135 194 2.38 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -20 -52 19 -183 -62
Debt-free Net Working Capital (DFNWC)		 0.00 569 920 787 485 349
Net Working Capital (NWC)		 0.00 550 879 787 485 349
Net Nonoperating Expense (NNE)		 -43 -21 -202 204 56 139
Net Nonoperating Obligations (NNO)		 0.00 -92 -712 -376 -134 37
Total Depreciation and Amortization (D&A)		 55 68 80 89 103 105
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -3.22% -7.39% 2.33% -21.18% -7.46%
Debt-free Net Working Capital to Revenue		 0.00% 92.98% 131.48% 97.94% 56.13% 42.33%
Net Working Capital to Revenue		 0.00% 89.91% 125.63% 97.94% 56.13% 42.33%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 176.61M 176.95M 177.19M 177.55M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($1.04) ($2.30)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 176.61M 176.95M 177.19M 177.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 166.41M 176.95M 176.92M 177.30M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.50 -14 43 16 -33 -63
Normalized NOPAT Margin		 -0.30% -2.23% 6.13% 1.94% -3.81% -7.69%
Pre Tax Income Margin		 15.05% 8.65% 38.34% -20.49% -10.31% -24.34%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 10.01 6.12 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -0.18 -1.32 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 5.73 6.12 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -4.46 -1.32 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Evotec

No quarterly metrics and ratios for Evotec are available.

Frequently Asked Questions About Evotec's Financials

When does Evotec's fiscal year end?

According to the most recent income statement we have on file, Evotec's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Evotec's net income changed over the last 5 years?

Evotec's net income appears to be on an upward trend, with a most recent value of -$202.96 million in 2024, falling from $41.87 million in 2019. The previous period was -$92.82 million in 2023.

What is Evotec's operating income?
Evotec's total operating income in 2024 was -$90.67 million, based on the following breakdown:
  • Total Gross Profit: $118.91 million
  • Total Operating Expenses: $209.58 million
How has Evotec revenue changed over the last 5 years?

Over the last 5 years, Evotec's total revenue changed from $501.02 million in 2019 to $824.94 million in 2024, a change of 64.7%.

How much debt does Evotec have?

Evotec's total liabilities were at $498.25 million at the end of 2024, a 9.0% decrease from 2023, and a 44.4% decrease since 2020.

How much cash does Evotec have?

In the past 4 years, Evotec's cash and equivalents has ranged from $317.14 million in 2024 to $791.50 million in 2021, and is currently $317.14 million as of their latest financial filing in 2024.

How has Evotec's book value per share changed over the last 5 years?

Over the last 5 years, Evotec's book value per share changed from 0.00 in 2019 to 5.56 in 2024, a change of 556.5%.


Related Companies

This page (OTCMKTS:EVTCY) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
If you missed your chance with Tesla...
Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...
Brownstone Research | Sponsored
Will May start the next "Great Depression?"
You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...
Behind the Markets | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...
Banyan Hill Publishing | Sponsored